FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 1954126 · Received January 10, 2011

Report

Report Number
2124215-2010-24287
Event Type
Malfunction
Date Received
January 10, 2011
Date of Event
December 15, 2010
Report Date
December 23, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE SALES REPRESENTATIVE CONFIRMED THE ISSUE WAS RESOLVED BY CHANGING THE LEAD CONFIGURATION TO DISTAL TO CAN WHICH RESULTED IN SATISFACTORY SHOCK IMPEDANCE MEASUREMENTS. NO FURTHER ISSUES WERE OBSERVED.

Additional Manufacturer Narrative · 1

AT THIS TIME THE DEVICE AND RIGHT VENTRICULAR LEAD REMAIN IN SERVICE. EFFORTS TO OBTAIN ADDITIONAL INFORMATION WERE MADE. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT AN ALERT WAS DETECTED DUE TO HIGH SHOCK IMPEDANCE VALUES. THE REASON FOR THE OUT OF RANGE SHOCK IMPEDANCES WAS NOT PROVIDED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 76 YR (B)(4)| (B)(4)| (B)(4)